These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32873770)

  • 1. Analysis of Clinical Characteristics, Pathological Changes and Changes of Interleukin-6 (IL-6) and C-Reactive Protein (CRP) in Children with Castleman's Disease.
    Hu C; Zou Y; Pan J; Yang J; Yang T; Tan T; Li J
    Med Sci Monit; 2020 Aug; 26():e924783. PubMed ID: 32873770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.
    Sun C; Xu G; Lin J
    Clin Lab; 2018 Oct; 64(10):1671-1678. PubMed ID: 30336525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
    Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
    Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
    Nishimoto N; Sasai M; Shima Y; Nakagawa M; Matsumoto T; Shirai T; Kishimoto T; Yoshizaki K
    Blood; 2000 Jan; 95(1):56-61. PubMed ID: 10607684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Features and Prognosis of Patients with Castleman's Disease].
    Huang XJ; Zhang XL; Wei XF; Liang XQ; Fu Y; Zhao YY; Li QF; Zhang QK; Feng YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):135-140. PubMed ID: 36765490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
    Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
    Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
    Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
    Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of 41 cases of head and neck Castleman's disease].
    Xue JF; Hao Q; Zhang YM; Cao PD; Song SP; Hu RF; Jin S
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):610-614. PubMed ID: 30122000
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary hyaline vascular Castleman disease of the kidney: case report and literature review.
    Li Y; Zhao H; Su B; Yang C; Li S; Fu W
    Diagn Pathol; 2019 Aug; 14(1):94. PubMed ID: 31439011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.
    Ikeda S; Chisuwa H; Kawasaki S; Ozawa J; Hoshii Y; Yokota T; Aoi T
    J Clin Pathol; 1997 Nov; 50(11):965-7. PubMed ID: 9462253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.
    Kinney MC; Hummell DS; Villiger PM; Hourigan A; Rollins-Smith L; Glick AD; Lawton AR
    J Clin Immunol; 1994 Nov; 14(6):382-90. PubMed ID: 7883866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of 44 patients with head and neck Castleman's disease.
    Wang T; Chen X; Chen W; Shi L; Liu J
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2625-2630. PubMed ID: 34480599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Castleman's disease--a two compartment model of HHV8 infection.
    Schulte KM; Talat N
    Nat Rev Clin Oncol; 2010 Sep; 7(9):533-43. PubMed ID: 20603649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
    Li P; Liu H; Li H; Li A; Yu G; Yin W
    Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5.
    Ishii T; Tatekawa T; Koseto M; Ishii M; Kobayashi H; Koike M; Fujii T; Saeki Y
    Eur J Haematol; 2003 Feb; 70(2):115-8. PubMed ID: 12581193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
    Koga T; Sumiyoshi R; Kawakami A; Yoshizaki K
    Mod Rheumatol; 2019 Mar; 29(2):302-305. PubMed ID: 30285516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease.
    Sun PP; Yu XJ; Wang SX; Zhou XJ; Qu L; Zhang F; Ma YY; Liu G; Yang L
    Nephrology (Carlton); 2020 Feb; 25(2):125-134. PubMed ID: 31264312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
    Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
    Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease.
    Nishi J; Arimura K; Utsunomiya A; Yonezawa S; Kawakami K; Maeno N; Ijichi O; Ikarimoto N; Nakata M; Kitajima I; Fukushige T; Takamatsu H; Miyata K; Maruyama I
    Br J Haematol; 1999 Mar; 104(3):482-5. PubMed ID: 10086783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.